Final height in children with medulloblastoma treated with growth hormone.All Scholarly Works
Document TypeArticle, Peer-reviewed
AbstractBACKGROUND: Medulloblastoma is the most frequent primary solid central nervous system tumour in children. The 5-year survival rate is at present at about 60%. Height in general is severely compromised in survivors. The present study is an extension of the
Citation InformationHorm Res 2005;64(1):28-34. Epub 2005 Aug 11.